Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
65.9%
% of GNOM's 41 holdings also in WDNA
30.7%
% of WDNA's 91 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.4% | 2.2% | 2.2% |
|
SAREPTA THERAPEUTICS INC | 3.6% | 1.7% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 1.9% | 1.6% | 1.6% |
|
MYRIAD GENETICS INC | 2.3% | 1.4% | 1.4% |
|
BEAM THERAPEUTICS, INC. | 3.6% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to WDNA
 |
ENI SPA-SPONSORED ADR | 7.7% |
|
VERACYTE INC | 3.9% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
|
NATERA INC | 3.2% |
|
BIO-TECHNE CORPORATION | 3.2% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.1% |
|
QIAGEN NV | 3.1% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 3.1% |
|
ILLUMINA INC | 2.9% |
|
AGILENT TECHNOLOGIES INC | 2.9% |
GNOM Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -4.3% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
GERON CORP | -2.5% |
|
AGIOS PHARMACEUTICALS INC | -2.4% |
|
FATE THERAPEUTICS INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
ELI LILLY & CO | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.7% |
|
BRIDGEBIO PHARMA, INC. | -1.6% |